Investigative Urology - Results from #6900

Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis HMGA2 as a prognostic marker of bladder cancer - Abstract February 28, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Molecular characterization/individualization of prostate cancer - Session Highlights February 28, 2011

Development and validation of health beliefs model scale for prostate cancer screenings (HBM-PCS): Evidence from exploratory and confirmatory factor analyses - Abstract February 25, 2011

Long-term follow-up of HLA-A2+ patients with high-risk, hormone-sensitive prostate cancer vaccinated with the prostate specific antigen peptide homologue (PSA146-154) - Abstract February 24, 2011

A 20-gene model for molecular nodal staging of bladder cancer: Development and prospective assessment - Abstract February 24, 2011

Grape seed extract regulates androgen receptor-mediated transcription in prostate cancer cells through potent anti-histone acetyltransferase activity - Abstract February 23, 2011

Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression - Abstract February 23, 2011

The histone deacetylase inhibitor trichostatin a synergistically resensitizes a cisplatin resistant human bladder cancer cell line - Abstract February 23, 2011

Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis - Abstract February 22, 2011

Effects of bevacizumab on autocrine VEGF stimulation in bladder cancer cell lines - Abstract February 11, 2011

Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer - Abstract February 9, 2011

Excision repair cross-complementing group 1 (ERCC1) may predict the efficacy of chemoradiotherapy for bladder cancer - Abstract February 4, 2011

Receptor heterodimerization: A new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer - Abstract February 3, 2011

The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy - Abstract February 3, 2011

FUS/TLS is a novel mediator of androgen-dependent cell cycle progression and prostate cancer growth - Abstract February 3, 2011

A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer - Abstract November 11, 2010

Page 346 of 346